Similarly, conditions of chronic inflammation may lead to dysregulated STAMP2 expression in PCa that would provide advantages to the cancer cell, e.g., through increased ROS levels, which may increase the rate of mutational events. Here, STEAP4 is linked to posterior cortical atrophy.